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Recently, William Gerwick's group reported the newest addition, malyngamide 2, isolated from L. sordida collected from Papua New Guinea. 8 Malyngamides are characterized by a fatty acid side chain, which is most commonly 7S-methoxytetradec-4(E)-enoic acid (lyngbic acid). The other part of the malyngamides usually encloses a cyclic unit. In one notable example (malyngamide J) the cyclic ketone has a pendant 2,4-dimethoxyxylose. 9 Malyngamides O and P are the only examples 10 of acyclic molecules in this series. Malyngamide 3 (1) described here is the next example of an acyclic malyngamide.
Cyclic depsipeptides containing a unique 2,2-dimethyl-3-hydroxy-7-octynoic acid (Dhoya), 2,2-dimethyl-3-hydroxy-7-octenoic acid (Dhoea), or 2,2-dimethyl-3-hydroxyoctanoic acid (Dhoaa) were first reported by Scheuer's group from a marine mollusk. 11, 12 Subsequently, Richard Moore's 13 and William Gerwick's 14 groups have isolated several of these unique cyclic depsipeptides from L. majuscula. Here, we report the isolation, structure determination, and biological activity determination of two new cyclic depsipeptides that possess these distinctive moieties (Dhoea/Dhoya), namely, cocosamides A (2) and B (3), from L. majuscula collected from Cocos Lagoon, Guam. Interestingly, this is the first report of cyclic depsipeptides in this series with one ester linkage, while other related compounds reported thus far with these unique acids have two or more ester linkages. [11] [12] [13] [14] The sample of the marine cyanobacterium L. majuscula was collected from a patch reef near Cocos Island, Guam, in February 2001. The freeze-dried material was extracted with a mixture of EtOAc-MeOH (1:1) to afford a lipophilic extract, which was subsequently partitioned between EtOAc and H 2 O. The EtOAcsoluble portion was repeatedly fractionated by SiO 2 chromatography followed by reversed-phase C18 HPLC to give three new compounds, malyngamide 3 (1) and cocosamides A (2) and B (3), in addition to the known compounds malyngamide A, 4 malyngamide B, 3 and an unresolved mixture of majusculamides A and B.
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Malyngamide 3 (1) was obtained as a colorless, amorphous powder. The molecular formula C 28 H 47 ClN 2 O 7 was determined from HRESIMS data. Its infrared spectrum contained absorption due to an amide proton at 3320 cm -1 , an ester carbonyl at 1725 cm -1 , and an amide carbonyl at 1636 cm -1 . The 1 H and 13 C NMR spectra (Table 1) showed signature signals for the presence of the characteristic 7-methoxytetradec-4(E)-enoic acid moiety, suggesting compound 1 to be an analogue of the malyngamides.
Following the interpretation of DQF COSY and edited HSQC experiments, the 1 H and 13 C NMR signals were assignable to three partial structures, C-1 to C-4, C-8 to C-10, and C-2 0 to C-14 0 , and an isolated C-6 methylene group. In addition, the 1 H, 13 C, and edited HSQC spectra indicated the presence of signals for two O-Me groups (C-12, δ H 3.68, δ C 51.9 and C-15 0 , δ H 3.30, δ C 56.5), one N-Me (C-13, δ H 2.93, δ C 35.5), and four carbonyl groups (C-5, δ C 202.2; C-7, δ C 166.6; C-11, δ C 172.4; and C-1 0 , δ C 174.0). The chemical shift values for C-2 (δ C 131.4, C) and C-3 (δ H 6.08, s; δ C 120.7, CH) indicated the presence of a chloromethylene moiety in the C-1 to C-4 partial structure as in other malyngamides 4, 5, 16 and accounted for the chlorine atom in the molecular formula. HMBC correlations (Table 1) ABSTRACT: Malyngamide 3 (1) and cocosamides A (2) and B (3) were isolated from the lipophilic extract of a collection of Lyngbya majuscula from Cocos Lagoon, Guam. The planar structures of compounds 1-3 were determined by spectroscopic methods. The absolute configuration of 1 was determined by modified Mosher's method, NOESY data, and comparison with lyngbic acid (4). The absolute configurations of 2 and 3 were assigned by enantioselective HPLC analysis and comparison with the closely related compound pitipeptolide A (5). Compounds 1-3 showed weak cytotoxicity against MCF7 breast cancer and HT-29 colon cancer cells.
HMBC correlations from H-4a and H-4b (δ H 3.20, 3.15) to C-5 (δ C 202.2) and H 2 -6 (δ H 3.39) to the C-5 and C-7 (δ C 166.6) carbonyl groups extended the carbon chain to the amide carbonyl group. The HMBC correlations of N-H (δ H 7.26) to C-7 and C-8 (δ C 45.2), H-9 (δ H 4.17) to C-8, C-10 (δ C 38.9), and C-11 (δ C 172.4), and H 3 -12 (δ H 3.68) to the C-11 carbonyl group established the planar structure for the right-hand end of the molecule. The HMBC correlations from H 3 -13 (δ H 2.93) to the C-1 0 carbonyl (δ C 174.0) and to C-1 connected the fatty acid chain to the right-hand end of the molecule via an amide linkage, resembling other malyngamides. An E configuration was assigned for the C-4 0 /C-5 0 olefin on the basis of the coupling constant (15.7 Hz). 17 The NOESY spectrum of 1 did not show any crosspeaks between H-3 and H 2 -1 nor between H-3 and H 3 -13. However, the presence of a strong cross-peak between H-3 (δ H 6.08) and H-4b (δ H 3.15) established a Z configuration for the chloromethylene moiety in 1 as in isomalyngamides A and B. 17 In order to determine the configuration at C-7 0 , compound 1 was hydrolyzed under basic conditions to give lyngbic acid (4 16 and, thus, established a 7(S) configuration at the C-7 0 position in 1. The absolute configuration at C-9 of 1 was determined by the modified Mosher 0 s method. 18 Compound 1 was converted to (S)-and (R)-MTPA esters. The Δδ (= δ S -δ R ) values of (S)-and (R)-MTPA esters (-0.078 for Ha-8; -0.031 for Hb-8; þ0.028 for H 2 -10; þ0.072 for CH 3 -12) revealed the R configuration at C-9. These data confirmed the structure 1 for malyngamide 3.
Cocosamides A (2) and B (3) were obtained as white solids. The molecular weights of 2 and 3 differ by two mass units on the basis of HRESI/TOFMS analysis. The 1 H and 13 C NMR spectra were indicative of depsipeptides (Table 2) .
Following the interpretation of DQF COSY, edited HSQC, and HMBC experiments, the 1 H and 13 C NMR signals of 2 and 3 were assignable to six partial structures, which accounted for all atoms in both molecules. These partial structures consisted of the amino acids valine, proline, glycine, and two N-Mephenylalanines, besides 2,2-dimethyl-3-hydroxy-7-octenoic acid (Dhoea) in 2 and 2,2-dimethyl-3-hydroxy-7-octynoic acid (Dhoya) in 3. The 1 H NMR spectra showed the presence of three olefinic protons (δ H 5.76, H-7; δ H 4.96, 5.04, H-8a, b) in the spectrum of 2, while no olefinic protons were seen in the spectrum of 3, which instead revealed a characteristic acetylenic proton (δ H 1.96, t, J = 2.7 Hz, H-8). The 13 C spectrum of 2 indicated olefinic signals (δ C 138.0, CH, C-7; δ C 115.2, CH 2 , C-8), while the 13 C spectrum of 3 indicated acetylenic signals (δ C 83.6, C, C-7; δ C 69.2, CH, C-8). These data together with other data presented in Table 2 confirmed the presence of a 2,2-dimethyl-3-hydroxy-7-octenoic acid in 2 and 2,2-dimethyl-3-hydroxy-7-octynoic acid in 3, respectively. The residue sequences for 2 and 3 were determined from HMBC data, which showed linkages Val-NH to C-1, Me-25 to C-11, CH 2 -30 to C-16, Me-40 to C-26, Gly-NH to C-31, and H-3 to C-41, and these connections were confirmed by NOESY correlations. These data established the residue sequences as 1,6-anhydro[Dhoea-Val-N-Me-Phe(1)-Pro-N-Me-Phe(2)-Gly] for 2 and 1,6-anhydro[Dhoya-Val-N-Me-Phe(1)-Pro-N-MePhe(2)-Gly] for 3. The absolute configurations of the amino acids were determined by enantioselective HPLC analysis of the acid hydrolysates of 2 and 3. The analysis revealed Lconfigurations for valine, proline, and both N-Me-phenylalanines in compounds 2 and 3. Because we have isolated only small quantities of 2 and 3, the configuration at C-3 of the hydroxy acids (Dhoea and Dhoya) was investigated by comparison of NOE data with pitipeptolide A (5). 13 Pitipeptolide A (5) is a cyclic depsipeptide that has a (S)-Dhoya moiety, which is connected to L-valine and glycine, forming amide and ester linkages similar to compounds 2 and 3. The NOE data for 5 were not previously reported; 13 therefore, we used 5 that we isolated from another Lyngbya sample for NOE comparison studies. The 1 H NMR spectrum, HRMS, and specific rotation data for this sample matched those reported in the literature. 13, 19 The NOESY spectrum of 5 showed a strong correlation between H-3 (δ H 4.94) and H 3 -10 (δ H 1.15) and another correlation between H-4a (δ H 1.80) and H 3 -10. Similarly, strong correlations were observed between H-4b (δ H 1.58) and H 3 -9 (δ H 1.29) and methyl H 3 -9 and L-Val-NH (δ H 6.08). There was no correlation seen between H-3 and H 3 -9. These data clearly indicated that in 5 the methine (H-3) is closer to methyl H 3 -10 and away from methyl H 3 -9. Cocosamides A (2) and B (3) showed the same patterns of NOE correlations for H-3, H 3 -9, and H 3 -10. These data suggested a 3S configuration at C-3 in compounds 2 and 3.
Compounds 1-3 were tested for antiproliferative activity against MCF7 breast cancer and HT-29 colon cancer cells and found to be weakly active. Malyngamide 3 (1) showed cytotoxic Journal of Natural Products NOTE activity against MCF7 and HT-29 cells with IC 50 values of 29 and 48 μM, respectively. This is an about 10-fold weaker activity than reported for the closely related analogue malyngamide O. 10 Cocosamides A (2) and B (3) showed cytotoxic activity against HT-29 cells with IC 50 values of 24 and 11 μM, respectively. MCF7 cells were slightly less susceptible to both compounds, with IC 50 values of 30 μM for 2 and 39 μM for 3. The closely related pitipeptolides A and B exert similar activity against cancer cells. (2.9%) of EtOAc-soluble fraction and 2.24 g (0.6%) of BuOH-soluble material. The EtOAc-soluble fraction (9.56 g) was chromatographed on a column of SiO 2 (100 g) using a hexanes-EtOAc step gradient system followed by an EtOAc-MeOH step gradient to give 13 subfractions. The combined subfractions 7 to 9 (2.0 g), eluting with hexanes-75% EtOAc, was further chromatographed on a Si-column (100 g) using a hexanes-EtOAc step gradient system to give eight subfractions. Subfraction 6 (36 mg), eluting with hexanes-25% EtOAc, was further purified by reversed-phase HPLC (semiprep 250 Â 10 mm, 5 μm, RP-18, flow 3.0 mL/min) using 15% H 2 O-MeOH to give 3 mg of impure cocosamide B, 20 mg of majusculamides A and B, 4.0 mg of malyngamide 3 (1, yield, 0.001% dry wt), and 1.4 mg of cocosamide A (2, yield, 0.0004% dry wt). The impure cocosamide B fraction was further separated by reversed-phase HPLC using 30% H 2 O-MeOH to give 2.0 mg of cocosamide B (3, yield 0.0006% dry wt). R-MTPA ester of 1: Cell Viability Assays. ' ACKNOWLEDGMENT
